Clinical trial No longer in our active list Interventional Ages 18 to 28

Exercise approach for correcting muscle function in lower crossed syndrome

Official title: Sequential Core Stability Corrective Exercise Approach for Alignment And Muscle Function In Lower Crossed Syndrome

Run by Riphah International University · NCT05505851 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new exercise program to see if it can help young adults with Lower Crossed Syndrome improve their muscle function and posture.

Quick facts

Study typeInterventional
Ages18 Years to 28 Years
SexAll
Enrollment40 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab)
Trial IDNCT05505851 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy individuals aged 18 to 28 who have been diagnosed with lower crossed syndrome and exhibit abdominal muscle weakness.

Probably not a fit

Patients with a history of low back pain, spinal trauma, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of a Sequential Core Stability Corrective Exercise Approach on alignment and muscle function in individuals diagnosed with Lower Crossed Syndrome, a common postural disorder characterized by muscular imbalances. Participants aged 18 to 28 will be randomly assigned to either a control group or the exercise intervention group. The study will measure outcomes related to muscle function and alignment before and after the intervention, as well as one month post-intervention. Data will be analyzed using appropriate statistical methods to determine the effectiveness of the exercise approach.

Why it matters

Potential benefit: If successful, this approach could improve muscle function and alignment, potentially alleviating low back pain and enhancing overall physical health.

How similar studies have gone: While the specific Sequential Core Stability Corrective Exercise Approach may be novel, similar interventions targeting muscle imbalances have shown promise in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Age group between 18 to 28 years

  * No current incidence of low back pain or past history of low back dysfunction
  * Kendall double leg lowering test: Abdominal muscle weakness to the extent of not being able to maintain posterior pelvic tilt during a double leg lowering test in supine position.
  * Diagnosed with lower cross syndrome through assessment criteria of Janda muscle testing and assessment

Exclusion Criteria:

* • Having any history of low back pain, spinal trauma,

  * Joint dysfunction in past 3 months
  * Congenital deformities at hip or lumbar region,
  * Recent fracture to related joints in past 6 months
  * Any family history of cardiopulmonary disease
  * Any disease or urogenital tract
  * Participants having BMI above 30.
  * Recent history of hepatitis or Fatty liver or
  * Any athlete having high physical activity.
  * History of abdominal, hip or lumbar surgeries in past 3 months

Where it's running

  • Al-khumeini Trust Hospital
    Lahore, Punjab, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.